David Morris, MD,FACS

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    UroGen Pharma
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Taris Biomedical
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    UroGPO
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Myovant
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Tolmar
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Decipher Bio
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    GenomeDx
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Invitae
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Merck
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    AstraZeneca

Pages

Return to PARP Inhibitors: Best Practices in Advanced Prostate Cancer Care in the Community Webcast (2021)